Another negative chemoprevention trial: what can we learn?

Frank L Meyskens

Back

Journal article

Another negative chemoprevention trial: what can we learn?

Frank L Meyskens

Clinical cancer research : an official journal of the American Association for Cancer Research, Vol.14(1), pp.2-3

01/01/2008

Abstract

Animals

Antineoplastic Agents: therapeutic use

BCG vaccine

bladder carcinoma

cancer chemotherapy

cancer research

Chemoprevention: methods

chemoprophylaxis

clinical assessment

clinical study

clinical trial

Clinical Trials as Topic

colorectal adenoma

cyclooxygenase 2 inhibitor

drug mechanism

drug safety

editorial

eflornithine

etretinate

fenretinide

Fenretinide: therapeutic use

head and neck cancer

human

Humans

leukoplakia

low drug dose

Neoplasms

Neoplasms: prevention & control

nonhuman

placebo

priority journal

raloxifene

retinoic acid

risk benefit analysis

tamoxifen

treatment outcome

unspecified side effect

Antineoplastic Agents

Breast Cancer

Chemoprevention

Prostate Cancer

Metrics

6 Record Views

Details

Title: Another negative chemoprevention trial: what can we learn?
Creators: Frank L Meyskens
Publication Details: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol.14(1), pp.2-3
Publisher: eScholarship, University of California
Number of pages: 2 - 3
Identifiers: 991005970012302656
Academic Unit: Urology
Language: English
Resource Type: Journal article

Another negative chemoprevention trial: what can we learn?

Abstract

Related links

Metrics

Details